# ESTRADIOL VALERATE
> **ANDA216656** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2023-04-28
## Drug
- **FDA Application Number:** ANDA216656
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESTRADIOL VALERATE
- **Generic name:** ESTRADIOL VALERATE
- **Active ingredients:** ESTRADIOL VALERATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** Xiromed, LLC
- **First approval:** 2023-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216656)
---
*AI Analytics · CC0 1.0*